Literature DB >> 26935238

Expression of lactate dehydrogenase C in MDA‑MB‑231 cells and its role in tumor invasion and migration.

Lingying Kong1, Wei Du1, Zhaolei Cui2, Li Wang1, Zhi Yang1, Hongsheng Zhang1, Donghong Lin2.   

Abstract

The cancer/testis antigen (CTA) lactate dehydrogenase C (LDHC) is a unique LDH isoenzyme associated with glucose and adenosine triphosphate production in mammalian germ cells. However, the role of LDHC in cancer has thus far largely remained elusive. The present study described the expression status of LDHC in human MDA‑MB‑231 breast cancer cells as well as its role in tumor invasion and migration. Immunohistochemical analysis revealed endogenous LDHC expression in the cytoplasm and nuclei of MDA‑MB‑231 cells yielded. In addition, in vitro cell invasion and migration assays revealed that when LDHC expression was blocked by its specific inhibitor, cell invasion and migration were compromised in MDA‑MB‑231 cells. Of note, inhibition of LDHC was unable to induce apoptosis in MDA‑MB‑231 cells. The present study provided evidence that the LDHC enzyme acts as a CTA in breast carcinoma and exerts an essential role in tumor invasion and migration.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26935238     DOI: 10.3892/mmr.2016.4963

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  13 in total

1.  Correlation between promoter methylation of the LDH-C4 gene and DNMT expression in breast cancer and their prognostic significance.

Authors:  Jiandong Zhang; Fengxia Zhang; Fengqin Zhang; Hua Wu; Bei Zhang; Xiangyun Wu
Journal:  Oncol Lett       Date:  2021-12-01       Impact factor: 2.967

2.  Cancer-Testis Antigen LDH-C4 in Tissue, Serum, and Serum-Derived Exosomes Serves as a Promising Biomarker in Lung Adenocarcinoma.

Authors:  Wei Peng; Jin Chen; Yanping Xiao; Guangjian Su; Yan Chen; Zhaolei Cui
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

Review 3.  Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers.

Authors:  Nuria Gómez-Cebrián; Ayelén Rojas-Benedicto; Arturo Albors-Vaquer; José Antonio López-Guerrero; Antonio Pineda-Lucena; Leonor Puchades-Carrasco
Journal:  Metabolites       Date:  2019-03-08

Review 4.  Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment.

Authors:  Deepshikha Mishra; Debabrata Banerjee
Journal:  Cancers (Basel)       Date:  2019-05-29       Impact factor: 6.639

5.  Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy.

Authors:  Remy Thomas; Hibah Shaath; Adviti Naik; Salman M Toor; Eyad Elkord; Julie Decock
Journal:  Cancer Immunol Immunother       Date:  2020-01-13       Impact factor: 6.968

Review 6.  Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors.

Authors:  Adviti Naik; Julie Decock
Journal:  Front Oncol       Date:  2020-11-26       Impact factor: 6.244

7.  Cancer-testis antigen lactate dehydrogenase C4 in hepatocellular carcinoma: a promising biomarker for early diagnosis, efficacy evaluation and prognosis prediction.

Authors:  Zhaolei Cui; Yun Li; Yanni Gao; Lingying Kong; Yingfeng Lin; Yan Chen
Journal:  Aging (Albany NY)       Date:  2020-10-09       Impact factor: 5.682

8.  Construction and validation of a metabolic gene-associated prognostic model for cervical carcinoma and the role on tumor microenvironment and immunity.

Authors:  Jinzhi Huang; Fei Luo; Mingjie Shi; Jiaxin Luo; Choudi Ma; Shangzheng Li; Yue Wei; Runmin Guo; Ting Li
Journal:  Aging (Albany NY)       Date:  2021-12-01       Impact factor: 5.682

9.  The cancer-testis antigen a-kinase anchor protein 3 facilitates breast cancer progression via activation of the PTEN/PI3K/AKT/mTOR signaling.

Authors:  Chuan-Hua Zhan; Dong-Shen Ding; Wei Zhang; Hong-Liang Wang; Zhe-Yu Mao; Guo-Jun Liu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

10.  Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation.

Authors:  Chuanyi Zhang; Xinzhou Deng; Li Qiu; Feng Peng; Shanshan Geng; Li Shen; Zhiguo Luo
Journal:  J Cancer       Date:  2018-06-23       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.